PSPA7_4558 is synthesized in E. coli, leveraging bacterial expression systems for scalability. Post-expression, purification involves:
Membrane proteins are central to Pseudomonas aeruginosa virulence, enabling:
Toxin Secretion: Type II/III secretion systems export virulence factors like exotoxin A and LasA/B .
Immune Evasion: Outer membrane vesicles (OMVs) deliver antigens to host cells, modulating immune responses .
Antigenic Targets: Recombinant OMVs (e.g., OMV-PH) have been engineered for vaccines, offering cross-protection against diverse Pseudomonas strains .
KEGG: pap:PSPA7_4558
The full amino acid sequence of Pseudomonas aeruginosa UPF0761 membrane protein PSPA7_4558 consists of 411 amino acids as follows:
MREHFNDGIEFARFLAHRFVTDKAPNSAAALTYTTLFAVVPMMTVMFSMLSLIPAFHGMGESIQTFIFRNFVPSAGEAVETYLKSFTTQARHLTWVGVVFLAVTAFTMLVTIEKAFNEIWRVRQPRRGVGRFLLYWAILSLGPLLLGAGFAVTTYITSLSLLHGPDALPGAETLLGLMPLAFSVAAFTLLYSAVPNARVPVRHALMGGMFTAVLFEAAKTLFGLYVSLFPGYQLIYGAFATVPIFLLWIYLSWMIVLFGAVLVCNLSSSRLWRRRSLPKPIVLLGVLRVFHQRQQLGQSMRLVHLHRAGWLLPEDEWEELLDFLEKEQFVCRVGGGEWVLCRDLGSYSLHRLLNRCPWPMPSRERMPAQLDEAWYPAFQQAMERLQAEQERLFGESLAHWLAEGNASAKVT
When designing experiments involving this protein, researchers should consider that this sequence represents the full-length protein without any modifications. For functional studies, it may be important to ensure the complete sequence is properly expressed to maintain native structure and function.
Based on established protocols, E. coli represents the preferred expression system for recombinant PSPA7_4558 production . The available recombinant versions typically include an N-terminal His-tag to facilitate purification .
When implementing this expression system, researchers should:
Select appropriate E. coli strains optimized for membrane protein expression (e.g., C41(DE3), C43(DE3) or Lemo21)
Consider induction conditions carefully, as membrane proteins often benefit from lower induction temperatures (16-20°C)
Test multiple detergents during extraction and purification to identify optimal solubilization conditions
Verify protein folding through functional assays, as membrane proteins can misfold during heterologous expression
For experimental design, variable manipulation should include testing different growth media compositions, induction points, and purification strategies to optimize yield of properly folded protein .
PSPA7_4558 stability is best maintained through proper storage protocols. The lyophilized form of the protein offers the greatest stability for long-term storage . Recommended storage procedures include:
Store the lyophilized powder at -20°C/-80°C upon receipt
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (with 50% being optimal) to prevent freeze-thaw damage
Aliquot the reconstituted protein to minimize freeze-thaw cycles
The stock buffer composition typically consists of Tris/PBS-based buffer with 6% Trehalose at pH 8.0 . Researchers should note that repeated freeze-thaw cycles significantly degrade membrane proteins and should therefore be avoided through proper aliquoting strategies.
As PSPA7_4558 is typically produced with a His-tag, affinity chromatography represents the primary purification method . A methodological approach to purification should include:
Initial capture using Ni-NTA or IMAC affinity chromatography
Detergent screening to identify optimal solubilization conditions
Buffer optimization to maintain protein stability during purification
Secondary purification steps such as size exclusion chromatography to achieve higher purity
Quality control assessment through SDS-PAGE (>90% purity is typically achievable)
When designing purification protocols, researchers should consider that membrane proteins often require specific detergent concentrations above their critical micelle concentration to remain soluble while preserving native structure.
While specific functional information for PSPA7_4558 is limited in the available literature, methodological approaches for characterizing UPF0761 family membrane proteins typically include:
Membrane integration assays to confirm proper localization
Protein-protein interaction studies using pull-down assays or yeast two-hybrid systems
Lipid binding assays to identify potential interactions with membrane components
Structural analyses using circular dichroism to assess secondary structure composition
Potential transport assays if the protein functions as a transporter
Experimental design for functional characterization should employ a systematic approach with appropriate controls. Researchers should initially establish baseline functional parameters and then proceed to more complex analyses . Since PSPA7_4558 is classified as an "UPF" (Uncharacterized Protein Family) protein, determining its function represents a significant research opportunity requiring careful experimental design.
Identifying interaction partners requires systematic experimental approaches. Methodological strategies include:
Affinity purification coupled with mass spectrometry (AP-MS)
Express tagged PSPA7_4558 in appropriate Pseudomonas strains
Perform crosslinking to capture transient interactions
Purify protein complexes using tag-based affinity methods
Identify co-purifying proteins through mass spectrometry
Yeast two-hybrid screening
Create bait constructs with PSPA7_4558 domains
Screen against Pseudomonas aeruginosa genomic libraries
Validate interactions through secondary confirmation methods
Proximity-based labeling approaches (BioID, APEX)
Express PSPA7_4558 fused to a proximity labeling enzyme
Identify proteins in close proximity through biotinylation
Purify and identify labeled proteins
When designing interaction studies, researchers should consider experimental controls including:
Non-specific binding controls using unrelated membrane proteins
Domain-specific constructs to map interaction regions
Validation through reciprocal pull-down experiments
The experimental design should incorporate randomization of samples to prevent batch effects and ensure reproducibility .
As a membrane protein, PSPA7_4558 presents unique structural analysis challenges. Researchers should consider a hierarchical approach:
Experimental design considerations should include:
Detergent screening to identify conditions that maintain native structure
Construct optimization to identify stable domains
Lipid reconstitution to mimic native membrane environment
Control experiments with known membrane proteins of similar size
Researchers should employ a systematic variable manipulation approach to optimize conditions for each structural technique .
For mechanistic studies of membrane proteins like PSPA7_4558, reconstitution into model membrane systems provides a controlled environment. Methodological approaches include:
Liposome reconstitution
Prepare liposomes with defined lipid composition
Incorporate purified PSPA7_4558 using detergent-mediated methods
Remove detergent through dialysis or adsorption
Verify incorporation through proteoliposome flotation assays
Nanodiscs preparation
Assemble nanodiscs with membrane scaffold proteins and lipids
Incorporate PSPA7_4558 during nanodisc formation
Purify PSPA7_4558-containing nanodiscs by size exclusion chromatography
Confirm protein orientation using protease protection assays
Supported lipid bilayers
Form bilayers on solid supports (e.g., mica, glass)
Incorporate PSPA7_4558 through vesicle fusion or direct reconstitution
Analyze protein behavior using surface-sensitive techniques
Experimental design should include controls for:
Protein:lipid ratios to optimize incorporation efficiency
Lipid composition to mimic bacterial membrane environments
Orientation control to ensure physiologically relevant topology
Function verification through appropriate assays after reconstitution
These approaches provide a platform for studying PSPA7_4558 in a controlled membrane environment that can be systematically manipulated to understand structure-function relationships .
Understanding PSPA7_4558's potential role in pathogenicity requires multi-faceted experimental approaches:
Gene knockout and complementation studies
Generate PSPA7_4558 deletion mutants in P. aeruginosa
Assess phenotypic changes in virulence models
Complement with wild-type and mutant versions to confirm specificity
Infection models
Compare wild-type and PSPA7_4558 mutant strains in relevant infection models
Assess bacterial burden, host response, and pathogenicity markers
Analyze tissue-specific effects during infection progression
Transcriptomic and proteomic profiling
Compare expression profiles between wild-type and mutant strains
Identify co-regulated genes during infection conditions
Discover potential regulatory networks involving PSPA7_4558
Experimental design considerations should include:
Proper randomization of experimental groups
Blinded assessment of infection outcomes
Appropriate statistical power calculations for animal studies
Multiple time points to capture dynamic processes
Controls for potential polar effects in genetic manipulations
These methodological approaches provide complementary data on PSPA7_4558's potential role in virulence while adhering to rigorous experimental design principles .
Rigorous experimental design for PSPA7_4558 studies requires comprehensive controls:
Expression controls
Empty vector controls to account for expression system effects
Alternative tagged proteins to validate tag-specific behaviors
Wild-type vs. mutant constructs to establish structure-function relationships
Functional controls
Heat-inactivated protein to distinguish active vs. passive effects
Known membrane proteins with similar characteristics for comparative analysis
Concentration gradients to establish dose-dependent effects
Technical controls
Multiple biological replicates to ensure reproducibility
Different protein preparations to account for batch variation
Different expression lots to minimize preparation artifacts
When designing experiments, researchers should implement variable manipulation systematically, manipulating independent variables (e.g., protein concentration, buffer conditions) to observe effects on dependent variables (e.g., binding affinity, activity) . This approach helps establish causality through proper experimental design.
Membrane protein topology determination requires multiple complementary approaches:
Protease accessibility assays
Treat intact membrane vesicles with proteases
Identify protected fragments through Western blotting
Compare with detergent-solubilized samples to identify protected domains
Substituted cysteine accessibility method (SCAM)
Introduce cysteine residues at predicted transmembrane boundaries
Treat with membrane-impermeable sulfhydryl reagents
Identify accessible regions through labeling patterns
Fluorescence-based approaches
Introduce fluorescent probes at specific positions
Measure environmental sensitivity of fluorescence
Determine membrane-embedded vs. solvent-exposed regions
Experimental design should incorporate:
Multiple prediction algorithms to establish topology hypotheses
Systematic mutation of key residues throughout the protein
Complementary techniques to validate findings
Controls with known membrane proteins of established topology
Randomization of sample analysis to prevent bias
These methodological approaches provide convergent evidence for PSPA7_4558 membrane topology while adhering to rigorous experimental design principles .
Investigating potential post-translational modifications (PTMs) of PSPA7_4558 requires careful experimental design:
Mass spectrometry-based approaches
Digest purified protein with multiple proteases to maximize coverage
Use different fragmentation methods (CID, ETD, HCD) for comprehensive analysis
Implement label-free and isotope-labeled quantification for modification stoichiometry
Compare different growth conditions to identify regulated modifications
Targeted analysis of specific modifications
Phosphorylation: Use phospho-specific antibodies and phosphatase treatments
Glycosylation: Employ glycosidase digestions and lectin-based detection
Lipid modifications: Apply fatty acid analysis and click chemistry approaches
Site-directed mutagenesis validation
Mutate putative modification sites to non-modifiable residues
Assess functional consequences through activity assays
Compare with wild-type protein under identical conditions
Experimental design considerations should include:
Appropriate controls including unmodified recombinant protein
Multiple biological replicates to account for modification heterogeneity
Comparison between heterologous and native expression systems
Technical controls for each modification-specific detection method
These approaches facilitate comprehensive analysis of PSPA7_4558 PTMs through rigorous experimental design and methodology .